OSTEONIC Co., Ltd.: Exports Surpass Domestic Sales in Q3… European Sales Up 77%
Achieved Cumulative Third-Quarter Revenue of 39.8 Billion Won and Operating Profit of 7.4 Billion Won
Expanding Exports of Dental Implants… Entering the Spinal Surgery Robot Business
[Edaily Reporter NA EUN-KYUNG ] OSTEONIC Co., Ltd.(226400)’s exports surpassed its domestic sales in the third quarter of this year. This is the result of expanded overseas sales, driven primarily by dental implants sold on credit. The company has also moved to secure synergies with its existing implant business by recently acquiring a U.S.-based spinal surgery robotics company.
OSTEONIC Co., Ltd. announced on the 16th that it recorded cumulative consolidated revenue of 39.76 billion won, operating profit of 7.45 billion won, and net income of 4.81 billion won for the third quarter of this year. These figures represent year-over-year increases of 22.8%, 15.1%, and 28.0%, respectively.
Third-quarter export revenue alone totaled 6.84 billion won, slightly exceeding domestic revenue of 6.82 billion won. During the same period last year, domestic revenue was 6.16 billion won, while exports totaled 5.79 billion won. Domestic revenue rose by 10.8%, while exports increased by 17.9%, resulting in a reversal of the trend.
The growth of overseas operations is also evident in regional performance. Cumulative sales in Europe for the first three quarters of this year reached 4.17 billion won, a 77.3% increase compared to the same period last year. Sales in the Americas also rose by 32.3% to 9.07 billion won. During the same period, the growth rate for domestic sales was 14.9%.
By product, the “Trauma” line of trauma implants—used to stabilize fractured bones—showed particularly strong growth. Third-quarter revenue for this line rose 52.6% year-over-year, with exports surging 114.9%. The company explained that orders have been expanding in Central and South America and other regions since receiving approval from the U.S. Food and Drug Administration (FDA) last year.
OSTEONIC Co., Ltd. supplies its “SportsMedicine” product line—used to treat sports injuries—to Zimmer Biomet, a global medical device company. For its “CMF” product line, which consists of craniofacial reconstruction implants, the company has signed a supply agreement with Germany’s B. Braun. The “Trauma” product line is expanding its overseas sales network primarily under its own brand.
The company is also cultivating its spinal implant business as a new growth engine. Third-quarter sales of the spinal product line increased by 42.2% compared to the same period last year. The company recently expanded into the surgical robotics sector by acquiring FoxEyes, a U.S.-based developer of AI-powered spinal surgery navigation robots.
Spinal implants are medical devices used in surgeries for spinal disorders to stabilize the spine or secure its stability. OSTEONIC Co., Ltd. plans to enhance its competitiveness in the global market by integrating its surgical robot technology with its proprietary spinal implant products.
LGELECTRONICS is partnering with the Korea Robot Industry Promotion Agency to enhance the safety and quality competitiveness of humanoid robots. Ahead of the unveiling of a bipedal robot in the first …
OSTEONIC Co., Ltd.(226400)reported cumulative sales of 39.8 billion won for the first three quarters of this year, driven by expanded overseas sales. Overseas sales slightly exceeded domestic sales in…
OSTEONIC Co., Ltd.(226400)’s exports surpassed its domestic sales in the third quarter of this year. This is the result of expanded overseas sales, driven primarily by dental implants sold on credit. …